A DEEP Group – Leeds Up & Go – has created a mural entitled ‘Keeping in touch’ to remind people of the importance of making connections and taking new opportunities after a dementia diagnosis. The mural is on display on the ginnel between Kirkstall Lane and St Michael’s Lane at the Headingley Rugby Stadium, and…
The Lewy Body Society has shared a new film featuring married couple Melanie and Keith talking to Consultant Admiral Nurse Rachel Thompson about living with sleep disturbances caused by Lewy body dementia. Keith lives with Lewy body dementia and began experiencing night terrors 30 years ago. Melanie and Keith explain their experiences and ways they’ve…
NHS England has published data for the first time that shows the diagnosis figures for dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD). Since 2023 the NHS has published figures for how many people have a sub-type diagnosis of Alzheimer’s disease, vascular dementia and mixed dementias. The latest NHS primary care dementia figures for…
A study being led by Dr Catherine Talbot at Bournemouth University is looking to develop resources to support people with dementia and their carers to use social media safely and effectively. Participants are wanted who are living with early-stage dementia and/or unpaid carers, regardless of whether they use social media or not. There is a…
The Alzheimer’s Society has opened a funding call for research proposals that tackle healthcare inequalities for people living with dementia and their carers. This has been fuelled by a report from The Office of Health Economics that highlights 110 healthcare inequalities faced by people living with dementia and 28 that affect carers. You can read…
Alzheimer’s Society has partnered with the Economic and Social Research Council (ESRC) and the National Institute for Health and Care Research (NIHR) to support investment in four research projects under the umbrella of Dementia Network Plus. The Projects/Networks who’ve been awarded funding are: EMPOWER Network Plus EQUADEM Network Plus SPINNET Network Plus Working with dementia Network Plus Each…
The US Food and Drug Administration (FDA) has approved donanemab, a drug for Alzheimer’s disease, for people in the US with confirmed amyloid positivity and a diagnosis of mild cognitive impairment (MCI) or early-stage Alzheimer’s disease. Donanemab is an antibody-based treatment intended to remove amyloid. It is given as an infusion into a person’s arm…
Share and Care Homeshare CIC, the largest homeshare organisation in the UK, has released its 2024 report. The report highlights how the primary reason for someone to consider a homeshare arrangement is memory issues, with 35% of householders living with dementia or other memory loss. This is closely followed by poor mobility, which accounts for…
To celebrate the 2024 National Playlist Day on 20 September, Playlist for Life has launched an awareness raising campaign inviting contributors to share photos and the songs associated with them for a ‘The Soundtrack of your life’ story. The campaign aims to celebrate special moments in a person’s life, and the musical soundtrack to those…
NHS England has reported that 487,432 people in England were given a diagnosis of dementia in June 2024. This is the highest rate of diagnosis, 65.0%, since the start of the pandemic. The NHS ambition for diagnosis is 66.7% of the total number of people estimated to have dementia. This figure was last met in…